Other Information.
−Removed: the quarter ended September 30, 2025, none of the Company’s directors or officers adopted , modified , or terminated a “Rule
−Removed: 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408(a) of
−Removed: Regulation S-K.
+Added: the quarter ended March 31, 2026, none of the Company’s directors or officers adopted , modified , or terminated a “Rule 10b5-1
+Added: trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408(a) of Regulation
following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report.
67 unchanged sentences
and Hudson Global Ventures, LLC, dated April 9, 2025 (incorporated by reference to Exhibit 10.3 of Wellgistics Health, Inc.’s Current Report on Form 8-K filed with the SEC on April 11, 2025).
−Removed: Executive Employment Agreement dated April 22, 2025, by and between the Company and Mark DiSiena (incorporated by reference to Exhibit 10.1 of Wellgistics Health, Inc.’s Current Report on Form 8-K filed with the SEC on April 24, 2025).
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
18 unchanged sentences
the undersigned hereunto duly authorized.
+Added: Prashant Patel
+Added: Executive Officer
Financial Officer
Financial Officer and Accounting Officer)
−Removed: November 19, 2025
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.